CLINICAL_TRIALS
trial_result
· 2024-05-22
Clinical Trial Update: Tenecteplase in Stroke Patients Between 4.5 and 24 Hours [Phase 3]
Summary
Phase 3 trial results for tenecteplase in ischemic stroke patients treated 4.5 to 24 hours after onset have completed, with results posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: THROMBOLYSIS | Phase 3 | Status: COMPLETED | Results posted: 2024-05-22